Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates

Peter A Senior1, Robert C Welsh, Charlotte G McDonald

  • 1Clinical Islet Transplant Program, University of Alberta, 8215 112th St., Edmonton, Alberta, Canada T6G 2C8. petersenior@ualberta.ca

Diabetes Care
|March 29, 2005
PubMed

Insights

Type 1 diabetes patients undergoing islet transplant evaluation often have undiagnosed coronary artery disease (CAD). Noninvasive tests frequently miss this asymptomatic CAD, highlighting the need for better risk assessment in this population.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality in type 1 diabetes patients.
  • Asymptomatic CAD is prevalent in uremic diabetic individuals, but its occurrence in nonuremic type 1 diabetes patients remains unclear.
  • Type 1 diabetic patients undergoing islet transplantation (ITX) with preserved renal function represent a specific cohort for evaluating CAD prevalence.

Purpose of the Study:

  • To determine the prevalence of CAD in nonuremic type 1 diabetic patients referred for ITX.
  • To evaluate the effectiveness of noninvasive cardiac investigations in detecting CAD in this population.
  • To identify predictors of CAD in type 1 diabetic ITX candidates.

Main Methods:

  • A prospective cohort study included 60 consecutive type 1 diabetic ITX candidates.
  • Coronary angiography was performed to define CAD (stenoses >50%).
  • Electrocardiographic stress testing (EST) and myocardial perfusion imaging (MPI) were used as noninvasive assessments; logistic regression analyzed predictive models.

Main Results:

  • Coronary artery disease (CAD) was found in 43% of asymptomatic type 1 diabetic patients.
  • CAD prevalence was associated with age, diabetes duration, hypertension, and smoking.
  • Noninvasive tests (EST, MPI) showed low sensitivity (0.04-0.17) for detecting CAD, though they aided in identifying patients needing revascularization.

Conclusions:

  • Nonuremic type 1 diabetic patients, particularly those with hypoglycemic unawareness or metabolic lability, face a high risk of asymptomatic CAD.
  • Current noninvasive cardiac investigations may not adequately identify CAD in this high-risk group.
  • Improved cardiovascular risk factor management and refined cardiac risk stratification strategies are essential for type 1 diabetes patients.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
351
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
400
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
934
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
230
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
615
Mass Analyzers: Common Types01:19

Mass Analyzers: Common Types

The quadrupole mass analyzer consists of four cylindrical metal rods arranged in a diamond carrying a DC voltage and a radio-frequency AC voltage. The motion of ions through the quadrupole depends on the field strength, causing only ions of a certain m/z to resonate successfully and strike the detector at a given field strength. Though the transmission rate for these analyzers is high, the exact elemental composition of the sample is not determined because of low resolution; however, they are...
1.4K